Everything You Need to Know about Viva Biotech 2026 Interim Results

News

}

Home / News / Company News / Company News detail

Time: 2026-08-26

Source: Viva Biotech

[Abstract]:Viva Biotech will continue to strengthen its one-stop, AI-driven innovative novel drug R&D platform and manufacturing service platform.

Previous Page：Unlocking TPD Modality Bottlenecks | One-Stop CRO Platform Empowers New-Drug Discovery of PROTACs, Molecular Glues and RIPTACs Next Page：Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth

Back

Media contact: vivapr@vivabiotech.com

This site uses cookies and your privacy choices are important to us

We use cookies to improve the user experience and to analyze website traffic. By clicking "Accept", you consent to the use of cookies on our website, such as cookies policies.